General Information of This Metabolic Reaction (MR) (ID: MR011806)
Formula
SVG example
Unclear
Reactant NCX 2057 Product Ferulic acid
Reactant Info Product Info
Metabolic Type Unclear - Unclear
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Produce The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR011803 NCX-1000 NCX 2057 Unclear - Unclear NCX-1000 [1]
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR011805 NCX 2057 Denitrated-NCX 2057 Unclear - Unclear NCX-1000 [1]
MR011804 NCX 2057 Hydroxy-butyl nitrate Unclear - Unclear NCX-1000 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR009203 3,4-Dihydroxycinnamic Acid Ferulic acid Unclear - Unclear 3,4-Dihydroxycinnamic Acid [2]
MR009201 DHFA FA Unclear - Unclear 3,4-Dihydroxycinnamic Acid [3]
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR009204 Ferulic acid Ferulic acid-4'-O-glucuronide Unclear - Unclear 3,4-Dihydroxycinnamic Acid [2]
MR009205 Ferulic acid Ferulic acid-4'-O-sulfate Unclear - Unclear 3,4-Dihydroxycinnamic Acid [2]
References
1 Treatment of portal hypertension with NCX-1000, a liver-specific NO donor. A review of its current status
2 Absorption, disposition, metabolism, and excretion of [3-(14)C]caffeic acid in rats
3 Metabolism of caffeic acid by isolated rat hepatocytes and subcellular fractions

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.